Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 16.85
+0.20 (1.20%)
At close: Aug 27, 2026
Vytrus Biotech Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 2.9 | 1.02 | 0.54 | 0.61 | 0.45 |
Depreciation & Amortization | 0.24 | 0.19 | 0.19 | 0.15 | 0.58 |
Other Amortization | 0.74 | 0.64 | 0.53 | 0.54 | - |
Asset Writedown & Restructuring Costs | 0 | - | - | - | - |
Other Operating Activities | 0.45 | -0.25 | -0.09 | 0.08 | -0.7 |
Change in Accounts Receivable | -0.52 | -0.08 | -0.11 | -0.22 | -0.06 |
Change in Inventory | -0.1 | 0.03 | -0.14 | -0.16 | -0.04 |
Change in Accounts Payable | 0.3 | 0.21 | -0.02 | 0.07 | 0.22 |
Change in Other Net Operating Assets | -0.1 | 0.09 | -0.01 | -0.05 | 0 |
Operating Cash Flow | 3.9 | 1.84 | 0.9 | 1.03 | 0.45 |
Operating Cash Flow Growth | 111.52% | 103.87% | -11.86% | 129.06% | - |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -1.01 | -0.1 | -0.14 | -0.42 | -0.22 |
Cash Acquisitions | - | -0 | - | - | - |
Sale (Purchase) of Intangibles | -1.67 | -1.1 | -1.02 | -0.87 | -0.05 |
Sale (Purchase) of Real Estate | - | - | - | 0 | - |
Investment in Securities | -0.08 | 0 | -0.02 | -0.03 | -0.03 |
Investing Cash Flow | -2.76 | -1.2 | -1.18 | -1.33 | -0.3 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | 0.18 | 0.2 | 1.65 | 0.38 | 0.27 |
Long-Term Debt Repaid | -0.65 | -0.61 | -0.68 | -0.35 | -0.27 |
Net Debt Issued (Repaid) | -0.47 | -0.41 | 0.96 | 0.03 | -0.01 |
Issuance of Common Stock | 0.82 | 1.29 | 0.12 | 0.17 | 0.25 |
Repurchase of Common Stock | -0.87 | -0.14 | -0.42 | -0.46 | -0.2 |
Other Financing Activities | 0.22 | 0.04 | - | - | - |
Financing Cash Flow | -0.29 | 0.78 | 0.66 | -0.26 | 0.05 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 0.85 | 1.42 | 0.38 | -0.56 | 0.19 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 2.89 | 1.74 | 0.76 | 0.61 | 0.23 |
Free Cash Flow Growth | 65.63% | 128.46% | 25.94% | 166.43% | - |
Free Cash Flow Margin | 29.78% | 28.62% | 16.22% | 13.51% | 6.47% |
Free Cash Flow Per Share | 0.38 | 0.23 | 0.11 | - | 0.03 |
Levered Free Cash Flow | 0.08 | 0.47 | -1.04 | -0.37 | 0.57 |
Unlevered Free Cash Flow | 0.13 | 0.55 | -0.94 | -0.24 | 0.64 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.06 | 0.09 | 0.1 | 0.06 | 0.08 |
Cash Income Tax Paid | -0 | - | - | - | - |
Change in Working Capital | -0.42 | 0.24 | -0.27 | -0.36 | 0.12 |